In the present study, we demonstrated that targeting SF3B1 using pladienolide B strongly affected breast cancer proliferation by increasing sororin alternative splicing and affecting the nuclear phenotype similar to our candidate splicing factor knockdown. This evidence concerns the gene CDCA5 and breast cancer.